Ublituximab (TG-1101), a Novel Anti-CD20 Monoclonal for Rituximab Relapsed/Refractory B-cell Malignancies.

Drug Category : Array
Conference Category : Array
Lead Author : Changchun D, O'Connor O, et al.
Published Date : 14/06/2013
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2019/03/EHA2013PosterP325.pdf
Download Text : Download
Popup Confirmation? :
site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
astra-migrate-meta-layouts : set
Scroll to Top